We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis, Wyeth Unit Spar Over ReFacto Patent

Law360 (March 5, 2009, 12:00 AM EST) -- Pharmaceutical giant Novartis AG has asserted its rights over two patents for several anti-hemophiliac treatments in an ongoing battle with Wyeth subsidiary Genetics Institute over who legally owns the formula for...
To view the full article, register now.